$VRMMQ
Vroom, Inc.

2022 Q2 Form 10-Q Financial Statement

#000095017022008544 Filed on May 09, 2022

View on sec.gov

Income Statement

Concept 2022 Q2 2022 Q1 2021 Q1
Revenue $475.4M $923.8M $591.1M
YoY Change -37.6% 56.28% 57.31%
Cost Of Revenue $409.1M $842.1M $554.9M
YoY Change -41.46% 51.75% 55.28%
Gross Profit $66.36M $81.64M $36.18M
YoY Change 5.12% 125.67% 96.75%
Gross Profit Margin 13.96% 8.84% 6.12%
Selling, General & Admin $153.0M $188.0M $109.1M
YoY Change 23.48% 72.29% 86.9%
% of Gross Profit 230.56% 230.27% 301.62%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $10.12M $7.895M $2.906M
YoY Change 224.41% 171.68% 199.59%
% of Gross Profit 15.24% 9.67% 8.03%
Operating Expenses $153.0M $188.0M $109.1M
YoY Change 23.48% 72.29% 86.9%
Operating Profit -$100.1M -$315.9M -$75.53M
YoY Change 56.79% 318.25% 84.41%
Interest Expense $9.533M $9.380M $3.812M
YoY Change 145.7% 146.07% 34.89%
% of Operating Profit
Other Income/Expense, Net -$9.156M -$12.36M $15.00K
YoY Change -27845.45% -82486.67% -54.55%
Pretax Income -$114.8M -$333.7M -$77.03M
YoY Change 75.02% 333.19% 87.86%
Income Tax $256.0K -$23.24M $156.0K
% Of Pretax Income
Net Earnings -$115.1M -$310.5M -$77.19M
YoY Change 74.89% 302.21% 88.0%
Net Earnings / Revenue -24.21% -33.61% -13.06%
Basic Earnings Per Share -$0.83 -$2.26
Diluted Earnings Per Share -$833.5K -$2.262M -$569.7K
COMMON SHARES
Basic Shares Outstanding 138.1M 137.1M 135.6M
Diluted Shares Outstanding 138.1M 137.3M

Balance Sheet

Concept 2022 Q2 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $532.6M $600.7M $940.3M
YoY Change -63.61% -36.11% 453.77%
Cash & Equivalents $532.6M $600.7M $966.8M
Short-Term Investments
Other Short-Term Assets $215.2M $265.3M $51.30M
YoY Change 147.04% 417.09% 14.51%
Inventory $535.8M $741.4M $337.7M
Prepaid Expenses
Receivables $60.12M $103.9M $93.20M
Other Receivables $323.2M $148.2M $0.00
Total Short-Term Assets $1.667B $1.859B $1.423B
YoY Change -23.22% 30.72% 231.35%
LONG-TERM ASSETS
Property, Plant & Equipment $49.84M $44.66M $35.50M
YoY Change 132.91% 25.79% 38.67%
Goodwill $0.00 $0.00 $159.3M
YoY Change -100.0% -100.0% 103.79%
Intangibles $172.4M $179.2M
YoY Change
Long-Term Investments
YoY Change
Other Assets $28.53M $29.62M $16.50M
YoY Change 44.03% 79.54% 21.32%
Total Long-Term Assets $475.4M $479.3M $244.2M
YoY Change 90.53% 96.28% 107.3%
TOTAL ASSETS
Total Short-Term Assets $1.667B $1.859B $1.423B
Total Long-Term Assets $475.4M $479.3M $244.2M
Total Assets $2.142B $2.339B $1.667B
YoY Change -11.5% 40.32% 204.64%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $43.63M $52.17M $42.80M
YoY Change -37.5% 21.9% 167.5%
Accrued Expenses $107.1M $139.2M $30.40M
YoY Change 24.05% 357.75% 112.59%
Deferred Revenue $17.80M $73.35M
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $115.3M $138.9M $253.0M
YoY Change -68.28% -45.08% 53.06%
Total Short-Term Liabilities $946.1M $1.017B $455.1M
YoY Change 43.57% 123.54% 84.25%
LONG-TERM LIABILITIES
Long-Term Debt $674.3M $687.4M $0.00
YoY Change 10.73% -100.0%
Other Long-Term Liabilities $18.46M $16.68M $16.00M
YoY Change 415.01% 4.24% 6.67%
Total Long-Term Liabilities $692.8M $704.1M $16.00M
YoY Change 19230.05% 4300.66% 5.96%
TOTAL LIABILITIES
Total Short-Term Liabilities $946.1M $1.017B $455.1M
Total Long-Term Liabilities $692.8M $704.1M $16.00M
Total Liabilities $1.647B $1.730B $471.1M
YoY Change 28.3% 267.3% 79.67%
SHAREHOLDERS EQUITY
Retained Earnings -$1.574B -$1.459B
YoY Change 70.96%
Common Stock $2.069B $2.068B
YoY Change 0.58%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $495.1M $608.4M $1.196B
YoY Change
Total Liabilities & Shareholders Equity $2.142B $2.339B $1.667B
YoY Change -11.5% 40.32% 204.64%

Cashflow Statement

Concept 2022 Q2 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income -$115.1M -$310.5M -$77.19M
YoY Change 74.89% 302.21% 88.0%
Depreciation, Depletion And Amortization $10.12M $7.895M $2.906M
YoY Change 224.41% 171.68% 199.59%
Cash From Operating Activities -$122.4M -$15.08M $29.55M
YoY Change -32.5% -151.02% -217.53%
INVESTING ACTIVITIES
Capital Expenditures -$8.950M $7.096M $3.239M
YoY Change 56.93% 119.08% 90.64%
Acquisitions $268.2M $76.15M
YoY Change 252.21%
Other Investing Activities -$5.660M -$204.9M -$76.15M
YoY Change -113300.0% 169.03%
Cash From Investing Activities -$14.61M -$212.0M -$79.38M
YoY Change 155.96% 167.01% 4572.4%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 25.90M -190.2M -73.37M
YoY Change -96.41% 159.23% -864.29%
NET CHANGE
Cash From Operating Activities -122.4M -15.08M 29.55M
Cash From Investing Activities -14.61M -212.0M -79.38M
Cash From Financing Activities 25.90M -190.2M -73.37M
Net Change In Cash -111.1M -417.2M -123.2M
YoY Change -120.82% 238.67% 614.46%
FREE CASH FLOW
Cash From Operating Activities -$122.4M -$15.08M $29.55M
Capital Expenditures -$8.950M $7.096M $3.239M
Free Cash Flow -$113.5M -$22.17M $26.32M
YoY Change -35.41% -184.26% -198.03%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001580864
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
396849000
CY2022Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
744831000
CY2021Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
473042000
CY2022Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
68402000
CY2022Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
801971000
CY2022Q1 vrm Proceeds From Warehouse Credit Facilities Of Consolidated Variable Interest Entities
ProceedsFromWarehouseCreditFacilitiesOfConsolidatedVariableInterestEntities
49000000
CY2022Q1 vrm Repayments Of Warehouse Credit Facilities Of Consolidated Variable Interest Entities
RepaymentsOfWarehouseCreditFacilitiesOfConsolidatedVariableInterestEntities
227067000
CY2021Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2821000
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
82450000
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
001-39315
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
VROOM, INC.
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
90-1112566
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
1375 Broadway
CY2022Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Floor 11
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10018
CY2022Q1 dei City Area Code
CityAreaCode
855
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
524-1300
CY2022Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
CY2022Q1 dei Trading Symbol
TradingSymbol
VRM
CY2022Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
138068774
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
600721000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1132325000
CY2022Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
196809000
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
14800000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
8900000
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
103911000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
105433000
CY2022Q1 vrm Finance Receivables At Fair Value Current
FinanceReceivablesAtFairValueCurrent
14900000
CY2022Q1 us-gaap Loans Receivable Held For Sale Amount
LoansReceivableHeldForSaleAmount
117658000
CY2022Q1 us-gaap Inventory Net
InventoryNet
741368000
CY2021Q4 us-gaap Inventory Net
InventoryNet
726384000
CY2022Q1 vrm Beneficial Interests In Securitizations
BeneficialInterestsInSecuritizations
15603000
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
68457000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
55700000
CY2022Q1 us-gaap Assets Current
AssetsCurrent
1859427000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
2102292000
CY2022Q1 vrm Finance Receivables At Fair Value Noncurrent
FinanceReceivablesAtFairValueNoncurrent
210523000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
44657000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
37042000
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
179183000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
28207000
CY2021Q4 us-gaap Goodwill
Goodwill
158817000
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
15321000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
15359000
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
29624000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
25033000
CY2022Q1 us-gaap Assets
Assets
2338735000
CY2021Q4 us-gaap Assets
Assets
2366750000
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
52172000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
52651000
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
139156000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
121508000
CY2022Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
569941000
CY2021Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
512801000
CY2022Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
138935000
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
73354000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
75803000
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7412000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6889000
CY2022Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
36359000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
57604000
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1017329000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
827256000
CY2022Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
687426000
CY2021Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
610618000
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8937000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
9592000
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
16679000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4090000
CY2022Q1 us-gaap Liabilities
Liabilities
1730371000
CY2021Q4 us-gaap Liabilities
Liabilities
1451556000
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
137695521
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
137695521
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
137092891
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
137092891
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
135000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
135000
CY2022Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2067470000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2063841000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1459241000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1148782000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
608364000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
915194000
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2338735000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2366750000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
923775000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
591118000
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
842135000
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
554942000
CY2022Q1 us-gaap Gross Profit
GrossProfit
81640000
CY2021Q1 us-gaap Gross Profit
GrossProfit
36176000
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
187994000
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
109114000
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
7856000
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2594000
CY2022Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
201703000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-315913000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-75532000
CY2022Q1 us-gaap Interest Expense
InterestExpense
9380000
CY2021Q1 us-gaap Interest Expense
InterestExpense
3812000
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
3952000
CY2021Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
2296000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-12358000
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
15000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-333699000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-77033000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-23240000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
156000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-310459000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-77189000
CY2022Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.26
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.57
CY2022Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
137259629
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
135497511
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1227102000
CY2021Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
39030000
CY2021Q1 vrm Adjustments To Additional Paid In Capital Fair Value Of Unvested Stock Options Assumed For Acquisition
AdjustmentsToAdditionalPaidInCapitalFairValueOfUnvestedStockOptionsAssumedForAcquisition
1017000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2820000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2821000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-77189000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
1195601000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
915194000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3629000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-310459000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
608364000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-310459000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-77189000
CY2022Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
201703000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7895000
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2906000
CY2022Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1254000
CY2021Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
281000
CY2022Q1 us-gaap Gain Loss On Securitization Of Financial Assets
GainLossOnSecuritizationOfFinancialAssets
29617000
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-23855000
CY2022Q1 vrm Loss On Finance Receivables And Securitization Debt Net
LossOnFinanceReceivablesAndSecuritizationDebtNet
15725000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3629000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2820000
CY2022Q1 us-gaap Inventory Write Down
InventoryWriteDown
469000
CY2021Q1 us-gaap Inventory Write Down
InventoryWriteDown
-2551000
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1795000
CY2021Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1813000
CY2022Q1 us-gaap Payments For Origination And Purchases Of Loans Held For Sale
PaymentsForOriginationAndPurchasesOfLoansHeldForSale
118861000
CY2022Q1 vrm Increase Decrease In Principal Payments Received On Finance Receivables Held For Sale
IncreaseDecreaseInPrincipalPaymentsReceivedOnFinanceReceivablesHeldForSale
2659000
CY2022Q1 us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
272309000
CY2022Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
1705000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4331000
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
33140000
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
15453000
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-88502000
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-6928000
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1127000
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2763000
CY2021Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
650000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-6824000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
9568000
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
8036000
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
12194000
CY2022Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-2449000
CY2021Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
23376000
CY2022Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-21163000
CY2021Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
2751000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15078000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
29554000
CY2022Q1 vrm Principal Payments Received On Finance Receivables At Fair Value
PrincipalPaymentsReceivedOnFinanceReceivablesAtFairValue
-33570000
CY2022Q1 us-gaap Proceeds From Sale Of Finance Receivables
ProceedsFromSaleOfFinanceReceivables
29043000
CY2022Q1 vrm Principal Payments Received On Beneficial Interests
PrincipalPaymentsReceivedOnBeneficialInterests
-714000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7096000
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3239000
CY2022Q1 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
47900000
CY2022Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
268194000
CY2021Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
76145000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-211963000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-79384000
CY2022Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-875000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-190204000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-73372000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-417245000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-123202000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1214775000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1090039000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
797530000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
966837000
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
5991000
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
3525000
CY2022Q1 vrm Fair Value Of Beneficial Interests Received In Securitization Transactions
FairValueOfBeneficialInterestsReceivedInSecuritizationTransactions
16473000
CY2021Q1 vrm Issuance Of Common Stock For Acquisition Of Business
IssuanceOfCommonStockForAcquisitionOfBusiness
39030000
CY2021Q1 us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
1017000
CY2022Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Arial;font-style:italic;min-width:fit-content;">Use of Estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Arial;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Arial;min-width:fit-content;"> </span></p><p style="text-indent:6.773%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;min-width:fit-content;">The preparation of consolidated financial statements in accordance with U.S. GAAP requires management to make estimates, assumptions and judgments that affect the reported amounts of assets, liabilities, revenue, and expenses and related disclosures. On an ongoing basis, the Company evaluates its estimates, including, among others, those related to income taxes, the realizability of inventory, stock-based compensation, contingencies, revenue-related reserves, fair value measurements, goodwill, and useful lives of property and equipment and intangible assets. The Company bases its estimates on historical experience, market conditions, and on various other assumptions that are believed to be reasonable. Actual results may differ from these estimates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;min-width:fit-content;"> </span></p><p style="text-indent:6.773%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Arial;min-width:fit-content;"> </span></p><p style="text-indent:6.773%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;min-width:fit-content;">Due to the evolving and uncertain nature of COVID-19, it is reasonably possible that it could materially impact the Company’s estimates, particularly those noted above that require consideration of forecasted financial information, in the near to medium term. The ultimate impact will depend on numerous evolving factors that the Company may not be able to accurately predict, including the duration and extent of the pandemic, the impact of federal, state, local and foreign governmental actions, consumer behavior in response to the pandemic and other economic and operational conditions the Company may face.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;min-width:fit-content;"> </span></p>
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0
CY2022Q1 vrm Financing Receivable Held For Sale Valuation Allowances
FinancingReceivableHeldForSaleValuationAllowances
0
CY2022Q1 us-gaap Number Of Reporting Units
NumberOfReportingUnits
4
CY2022Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Arial;font-style:italic;min-width:fit-content;">Concentration of Credit Risk and Significant Customers</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Arial;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Arial;min-width:fit-content;"> </span></p><p style="text-indent:6.773%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;min-width:fit-content;">The Company’s principal financial instruments subject to potential concentration of credit risk are cash and cash equivalents and accounts receivable, which are unsecured. The Company’s cash balances are maintained at various large, reputable financial institutions. Deposits held with financial institutions may at times exceed the amount of insurance provided on such deposits. Generally, these deposits may be redeemed upon demand and, therefore, management believes they bear minimal risk. The Company’s cash equivalents primarily consist of money market funds that hold investments in highly liquid U.S. treasury securities and commercial paper investments. Concentration of credit risk with respect to accounts receivable is generally mitigated by a large customer base.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;min-width:fit-content;"> </span></p><p style="text-indent:6.773%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Arial;min-width:fit-content;"> </span></p><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;min-width:fit-content;">For the three months ended March 31, 2022 and 2021, no customer represented 10% or more of the Company’s revenues and no customer represented more than 10% of the Company’s accounts receivable as of March 31, 2022 and December 31, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;min-width:fit-content;">.</span>
CY2022Q1 vrm Reserve For Chargebacks
ReserveForChargebacks
10200000
CY2021Q4 vrm Reserve For Chargebacks
ReserveForChargebacks
9600000
CY2022Q1 vrm Cumulative Profit Sharing Payment Recognized
CumulativeProfitSharingPaymentRecognized
19700000
CY2021Q4 vrm Cumulative Profit Sharing Payment Recognized
CumulativeProfitSharingPaymentRecognized
17900000
CY2022Q1 vrm Percentage Of Servicing Fees Earned On Outstanding Principal Balance Of Finance Receivable
PercentageOfServicingFeesEarnedOnOutstandingPrincipalBalanceOfFinanceReceivable
0.04
CY2022Q1 us-gaap Revenue Practical Expedient Incremental Cost Of Obtaining Contract
RevenuePracticalExpedientIncrementalCostOfObtainingContract
true
CY2022Q1 vrm Proforma Adjustments Related To Non Recurring Acquisition Related Cost
ProformaAdjustmentsRelatedToNonRecurringAcquisitionRelatedCost
5700000
CY2021Q1 vrm Proforma Adjustments Related To Non Recurring Acquisition Related Cost
ProformaAdjustmentsRelatedToNonRecurringAcquisitionRelatedCost
5700000
CY2022Q1 vrm Non Recurring Tax Adjustment Benefit
NonRecurringTaxAdjustmentBenefit
24100000
CY2021Q1 vrm Non Recurring Tax Adjustment Benefit
NonRecurringTaxAdjustmentBenefit
-26200000
CY2022Q1 vrm Vehicles
Vehicles
737583000
CY2021Q4 vrm Vehicles
Vehicles
724542000
CY2022Q1 vrm Parts And Accessories
PartsAndAccessories
3785000
CY2021Q4 vrm Parts And Accessories
PartsAndAccessories
1842000
CY2022Q1 us-gaap Inventory Net
InventoryNet
741368000
CY2021Q4 us-gaap Inventory Net
InventoryNet
726384000
CY2022Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
22900000
CY2021Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
22400000
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
67943000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
57460000
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
23286000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
20418000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
44657000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
37042000
CY2020Q4 us-gaap Goodwill
Goodwill
78172000
CY2021Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
81134000
CY2021Q1 us-gaap Goodwill
Goodwill
159306000
CY2021Q4 us-gaap Goodwill
Goodwill
158817000
CY2022Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
42886000
CY2022Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
201703000
CY2022Q1 us-gaap Goodwill
Goodwill
0
CY2022Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
201700000
CY2021Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2022Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
190592000
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
11409000
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
179183000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
34592000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6385000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
28207000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5000000.0
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1400000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
20270000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths
27022000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo
27022000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree
27022000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour
21979000
CY2022Q1 vrm Finite Lived Intangible Assets Amortization Expense Rolling After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFour
55868000
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
179183000
CY2022Q1 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
14265000
CY2021Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
17546000
CY2022Q1 vrm Accrued Vehicle Related Expenses Current
AccruedVehicleRelatedExpensesCurrent
44665000
CY2021Q4 vrm Accrued Vehicle Related Expenses Current
AccruedVehicleRelatedExpensesCurrent
36459000
CY2022Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
35570000
CY2021Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
39163000
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
25161000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
16150000
CY2022Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
5189000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
4225000
CY2022Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
14306000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
7965000
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
139156000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
121508000
CY2022Q1 vrm Vehicle Payable Current
VehiclePayableCurrent
15981000
CY2021Q4 vrm Vehicle Payable Current
VehiclePayableCurrent
30647000
CY2022Q1 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
17675000
CY2021Q4 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
26522000
CY2022Q1 vrm Other Current
OtherCurrent
2703000
CY2021Q4 vrm Other Current
OtherCurrent
435000
CY2022Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
36359000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
57604000
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
6700000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
591118000
CY2022Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
138935000
CY2022Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
687426000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
610618000
CY2022Q1 us-gaap Long Term Debt
LongTermDebt
826361000
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
610618000
CY2022Q1 vrm Debt Instrument Initial Principal Amount
DebtInstrumentInitialPrincipalAmount
339660000
CY2022Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
206991000
CY2022Q1 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
204627000
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
110500000
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
64400000
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
25300000
CY2022Q1 us-gaap Pledged Assets Not Separately Reported Finance Receivables
PledgedAssetsNotSeparatelyReportedFinanceReceivables
218243000
CY2022Q1 us-gaap Pledged Assets Separately Reported Finance Receivables Pledged As Collateral At Fair Value
PledgedAssetsSeparatelyReportedFinanceReceivablesPledgedAsCollateralAtFairValue
189469000
CY2003Q3 us-gaap Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust Noncurrent
JuniorSubordinatedDebentureOwedToUnconsolidatedSubsidiaryTrustNoncurrent
10000000.0
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q1 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
On June 11, 2020, the Company amended its certificate of incorporation to effect a 2-for-1 forward stock split of shares of the Company’s outstanding common stock, such that each share of common stock, $0.001 par value became two shares of common stock, $0.001 par value per share.
CY2020Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
2
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2022Q1 us-gaap Common Stock Voting Rights
CommonStockVotingRights
one vote
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
5483716
CY2022Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2021Q1 us-gaap Gross Profit
GrossProfit
36176000
CY2022Q1 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
293750000
CY2021Q4 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
386100000
CY2022Q1 us-gaap Fair Value Assets And Liabilities Measured On Recurring Basis Gain Loss Included In Earnings
FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisGainLossIncludedInEarnings
-11550000
CY2021Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
0
CY2021Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
0
CY2022Q1 us-gaap Loans Receivable Held For Sale Amount
LoansReceivableHeldForSaleAmount
117658000
CY2022Q1 us-gaap Loans Held For Sale Fair Value Disclosure
LoansHeldForSaleFairValueDisclosure
123163000
CY2021Q1 vrm Finance Receivables Held For Sale Carrying Value
FinanceReceivablesHeldForSaleCarryingValue
0
CY2021Q1 vrm Finance Receivables Held For Sale Fair Value
FinanceReceivablesHeldForSaleFairValue
0
CY2022Q1 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
611424000
CY2021Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
610618000
CY2022Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4
CY2022Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
4
CY2022Q1 vrm Segment Assets
SegmentAssets
0
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
923775000
CY2022Q1 us-gaap Gross Profit
GrossProfit
81640000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
923775000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
591118000
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
187994000
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
109114000
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
7856000
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2594000
CY2022Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
201703000
CY2022Q1 us-gaap Interest Expense
InterestExpense
9380000
CY2021Q1 us-gaap Interest Expense
InterestExpense
3812000
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
3952000
CY2021Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
2296000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-12358000
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
15000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-333699000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-77033000
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0696
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0020
CY2022Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-310459000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-77189000
CY2022Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
137259629
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
135497511
CY2022Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.26
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.57
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
17372070
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6695400

Files In Submission

Name View Source Status
0000950170-22-008544-index-headers.html Edgar Link pending
0000950170-22-008544-index.html Edgar Link pending
0000950170-22-008544.txt Edgar Link pending
0000950170-22-008544-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
img173399739_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vrm-20220331.htm Edgar Link pending
vrm-20220331.xsd Edgar Link pending
vrm-20220331_cal.xml Edgar Link unprocessable
vrm-20220331_def.xml Edgar Link unprocessable
vrm-20220331_htm.xml Edgar Link completed
vrm-20220331_lab.xml Edgar Link unprocessable
vrm-20220331_pre.xml Edgar Link unprocessable
vrm-ex31_1.htm Edgar Link pending
vrm-ex31_2.htm Edgar Link pending
vrm-ex32_1.htm Edgar Link pending
vrm-ex32_2.htm Edgar Link pending